Dr Paul Bowyer

Dr Paul Bowyer leads the Malaria study area at National Institute for Biological Standards and Control (NIBSC), a centre of the Medicines and Healthcare products Regulatory Agency (MHRA).

Previously he studied at Imperial College London, receiving a MSci in chemistry (industrial placement at Syngenta / Zeneca Agrochemicals) and a PhD from the Division of Cell and Molecular Biology on the N-myristoyltransferase of Plasmodium falciparum. His post-doctoral studies at Stanford University School of Medicine (Bogyo Lab) and were focused on chemical biology and chemical proteomics of both Plasmodium falciparum and Toxoplasma gondii. Paul returned to the UK working in malaria drug discovery, first as a Principal Scientist at Pfizer and then at the London School of Hygiene and Tropical Medicine and MRC Technology.

At NIBSC, as well as developing standards and assisting in the harmonisation of P. falciparum biological assays, Paul is investigating the ability to, and mechanisms by which the malaria parasite adapts to various external pressures (eg. altered blood cells, pressure from the immune system).